Leslie Benet, PhD ’65:  A Pharmacologist Who Makes Medicines Work

From English Major to Pharmacokinetics Pioneer

Leslie Benet once planned to be an English professor. He wrote poems, earned an English degree, and showed his portfolio to mentor and Poet Laureate Donald Hall. Hall’s verdict was kind but clear: Benet would make a great professor, just not in English. Fortunately, he had a backup plan. Pharmacy was in his DNA. His father and uncle had founded a chain of pharmacies in Cincinnati, where he grew up behind the counter. Rather than dispensing medicines, he chose to understand how they work, studying pharmaceutical chemistry at UCSF and spending 61 years as a professor, reshaping how they are dosed worldwide.

Rewriting the Rules of Drug Dosing

Benet’s career orbited a deceptively simple question: How do you get the right drug, at the right dose, into the right patient, so it works without causing harm? “I don’t make the molecules,” he says. “I make the molecules work.” He helped shift the field from abstract laboratory measures to “clearance” — the body’s ability to eliminate a drug from the bloodstream — giving clinicians a practical tool for tailoring doses to each patient’s biology and disease. He was also among the first to show that the intestine, not just the liver, acts as a gatekeeper for drugs, a discovery so novel he patented it. He also led pivotal clinical studies demonstrating that generic drugs perform as well as brand-name medicines, helping make treatment more affordable and accessible.

Challenging 75 Years of Dogma

Now a professor emeritus, Benet is most excited about what he's doing today. He has applied Kirchhoff’s laws of physics — principles governing electrical circuits — to pharmacokinetics, treating how drugs move through the body like currents flowing through a network of pathways, creating a simpler framework that upends 75 years of dogma. His model explains what older approaches could not and opens the possibility that drug makers could one day separate efficacy from toxicity, achieving high effectiveness with far less harm. His office walls, covered floor to ceiling with plaques and honors, reflect a career marked by nearly every major award in pharmaceutical sciences, and he beams when he talks about training and mentoring more than 150 doctoral and postdoctoral scholars. “It is a thrill to both make discoveries and to teach mentees who will carry them forward.”